Latest Content

PBM critics heaped praise on reforms. A communications official at the trade group should turn its attention to how the pharmaceutical industry stifles competition and keeps prescription drug prices high.

Recent research compares sleep aids in apps—sonic sleep sounds, white noise and pink noise—and warns weak evidence may waste money and delay proven insomnia care.

Rural hospital study found text messaging intervention significantly improved medication adherence for heart failure patients, demonstrating that simple technology can reduce readmissions.

A large Korean, population-based study of more than 2 million women suggests that patterns across a woman’s reproductive life may influence ovarian cancer risk, with some factors increasing risk and others appearing protective.

Patients using GLP-1 medications may notice facial changes due to fat loss. Vasyukevich stresses education and options for maintaining a youthful appearance.

The award will involve patients with chronic disease and their families to inform clinical research, with an initial focus on diabetes.

Estimates show melanoma diagnoses continuing to climb in the United States, even as newer therapies continue to reduce deaths from advanced disease.

Ten Medicaid tech companies pledge over $600 million in support to help states meet new community engagement requirements and modernize eligibility systems.

A recent study found that older adults who received the shingles vaccine were biologically younger than those who didn’t, which suggests the vaccine may slow aspects of biological aging as well as prevent shingles.

Explore the impact of ACA tax credits on enrollment, premiums and healthcare access as Congress debates subsidy extensions for 2026 and beyond.

Yuvezzi is the first combination product that treats adults with presbyopia. It will be available in the second quarter of 2026.

Urgent care spending surges over 50% from 2018 to 2022, driven by increased visits, highlighting its vital role in healthcare access.

Although Medicaid expansion has been linked to lower mortality, significant racial disparities persist.

CMS announced 15 drugs for Medicare price negotiations under the IRA, representing $27 billion in spending and treating conditions such as diabetes, cancer, and autoimmune conditions. Here are three insights on the list from industry experts.

Chris Klomp, the director of Medicare and the deputy administrator at CMS, spoke about the proposed rule designed to curtail at-home risk assessments and other tactics that large insurers have used to game Medicare Advantage risk adjustment.

A new study has identified the brain connectivity patterns that lead to cognitive difficulties in patients with schizophrenia, suggesting potential targets for therapeutic intervention in early psychosis stages.

More Americans are tracking and changing their sleep habits, but the growing cultural focus on sleep data is also increasing anxiety, with orthosomnia leaving many people awake at night.

Proposed Medicare Advantage payment updates spark concern among insurers and investors, raising questions about risk adjustment and potential impacts on beneficiaries.

During an investor call, UnitedHealth Group executives talk about the steps it has taken to increase transparency, use technology to reshape its healthcare delivery and address how it adapting to financial pressures across its Medicare, Medicaid, and Affordable Care Act businesses.

Lung cancer remains the leading cause of cancer deaths in the U.S. in 2026 and is expected to account for an estimated 229,410 new cases.

Unrest is escalating in Minnesota after federal immigration officers killed two civilians including ICU nurse Alex Pretti, prompting more than 60 Minnesota CEOs and national nursing organizations to call for de-escalation, accountability and a transparent investigation of the incidents.

In a Q&A, Jeffrey Hogan, managing director and co-founder of Judi Group, talks about the importance of identifying hidden costs and contract conflicts of healthcare vendors.

Legislation reforms pharmacy benefit managers by mandating price transparency, eliminating certain compensation models, and providing CMS funding to enforce contract terms.

Medicare's 2024 initiative to address health-related social needs faces challenges, with over 25% of claims denied, highlighting barriers to effective care.

In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC Health + Hospitals, discusses the results of her latest case study on PrEP uptake and why it’s important to “celebrate success.”

In this interview, Danielly Fausto, Ph.D., physical education researcher at the Santa Catarina State University in Brazil, discusses the importance of midlife physical activity, how she’s come to terms with the initially "disappointing" results of her recent study and why it’s essential to keep talking about menopause.